Washington Trust Bank’s AstraZeneca AZN Stock Holding History

Washington Trust Bank’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-108	Closed	-$7K	–	1100
2016 Q2	$7K	Buy	108 +65	+151%	+$3.77K	﹤0.01%	594
2016 Q1	$2K	Buy	+43	New	+$2.58K	﹤0.01%	694
2015 Q3	–	Sell	-1,146	Closed	-$73K	–	769
2015 Q2	$73K	Sell	1,146 -2,000	-64%	-$137K	0.02%	355
2015 Q1	$215K	Sell	3,146 -300	-9%	-$20.8K	0.05%	191
2014 Q4	$243K	Hold	3,446	–	–	0.06%	188
2014 Q3	$246K	Buy	3,446 +2,000	+138%	+$146K	0.08%	188
2014 Q2	$107K	Hold	1,446	–	–	0.02%	353
2014 Q1	$94K	Buy	+1,446	New	+$93.4K	0.02%	377

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BIM

BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Washington Trust Bank's AZN Position: Q3 2016 in Review

Washington Trust Bank sold out of AstraZeneca (AZN) in Q3 2016, closing a stake of 108 shares — an estimated $7K sold.

Washington Trust Bank first reported a position in AZN in Q1 2014 and held it in 8 quarters. The position peaked at $246K in Q3 2014. 451 funds tracked by Wall St. Rank hold AZN as of Q3 2016.

Washington Trust Bank reported no remaining AstraZeneca position as of Q3 2016 after selling out during the quarter.
Washington Trust Bank sold 108 AstraZeneca shares in Q3 2016, an estimated $7K.
Washington Trust Bank first reported a position in AstraZeneca in Q1 2014 and held it in 8 quarters.
Washington Trust Bank's AstraZeneca position peaked at $246K in Q3 2014.
451 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2016.

Based on Washington Trust Bank's 13F filing for Q3 2016, filed 4 Oct 2016.